Solesence, Inc. is projected to rise to $1.54 by 2027, a +25% move from its current price of $1.23. SLSN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.16 | $1.23 | $1.30 | 0.00% |
| May 30 | $1.13 | $1.23 | $1.34 | -0.01% |
| May 31 | $1.11 | $1.23 | $1.36 | -0.01% |
| Jun 1 | $1.09 | $1.23 | $1.38 | -0.02% |
| Jun 2 | $1.08 | $1.23 | $1.40 | -0.02% |
| Jun 3 | $1.06 | $1.23 | $1.42 | -0.02% |
| Jun 4 | $1.05 | $1.23 | $1.44 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.05 | $1.23 | $1.44 | -0.03% |
| Week 2 | $0.9862 | $1.23 | $1.53 | -0.06% |
| Week 3 | $0.9383 | $1.23 | $1.61 | -0.08% |
| Week 4 | $0.8997 | $1.23 | $1.68 | -0.11% |
| Week 5 | $0.867 | $1.23 | $1.74 | -0.14% |
| Week 6 | $0.8384 | $1.23 | $1.80 | -0.17% |
| Week 7 | $0.8129 | $1.23 | $1.85 | -0.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Solesence, Inc. (SLSN) is a United States–based company operating in the Consumer Defensive sector. It provides engineered materials, formulation development, and commercial manufacturing services, including surface engineered zinc oxide and titanium dioxide ingredients.
It also offers skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients, and skin health products such as sunscreens and daily care products.
The company serves markets across medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications, and it targets skin health, beauty, and wellness sectors. It was formerly Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025.
Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Solesence, Inc. is currently priced at $1.25 with a market cap of $87.94M and a rank of 4309. The current price position sits within a near-term frame that shows a neutral outlook in the technical picture.
The stock’s moving averages stand at SMA50 $1.16 and SMA200 $2.14, with near-term support at $1.10 and resistance at $1.50. The thirty-day range runs from $0.8278 to $1.87, reflecting a tight swing around the current level.
Annualized volatility is listed at 100%, underscoring substantial near-term price fluctuations around the level around $1.25. The multi-year forecast points toward an upward price path, with 2026 averaging $1.25 and higher potential in later years, including a max forecast that climbs toward the upper end of the spectrum by 2050.
A major floor 34.1% below — a decisive break under it would weaken the trend.
The nearest floor, 10.6% below — buyers have tended to step in here.
The nearest ceiling, 22.0% above — a clean break opens room to run.
A major ceiling 36.3% above — clearing it would confirm fresh momentum.
Key SLSN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLSN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.28 | Sell | $1.26 | Sell |
| MA 10 | $1.27 | Sell | $1.27 | Sell |
| MA 20 | $1.29 | Sell | $1.27 | Sell |
| MA 50 | $1.18 | Buy | $1.26 | Sell |
| MA 100 | $1.26 | Sell | $1.44 | Sell |
| MA 200 | $2.12 | Sell | $1.84 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.46 | Neutral |
| Stoch RSI (14) | 9.77 | Buy |
| CCI (20) | -86.96 | Neutral |
| Williams %R (14) | -87.10 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -8.89 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 12.90 | Buy |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 50.94 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 1.26 | Sell |
| ADX (14) | 8.31 | Neutral |
| ATR (14) | 0.07 | Info |
Near-term sentiment is NEUTRAL. The RSI(14) is 50, and the stock trades around the blend of the SMA50 ($1.16) and SMA200 ($2.14).
Support is identified at $1.10 and resistance at $1.50, framing a tight near-term range. The thirty-day range is $0.8278 on the low to $1.87 on the high, highlighting the recent volatility within a narrow band.
Overall near-term volatility sits with an annualized figure of 100%, reflecting meaningful price movement potential relative to the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.81 | $1.23 | $1.78 | 0% | Neutral | |
| $1.11 | $1.54 | $2.32 | +25% | Bullish | |
| $1.33 | $1.96 | $3.13 | +59% | Bullish | |
| $1.47 | $2.28 | $3.82 | +85% | Bullish | |
| $1.25 | $2.03 | $3.54 | +65% | Bullish | |
| $1.23 | $2.09 | $3.76 | +70% | Bullish | |
| $1.21 | $2.15 | $4.00 | +75% | Bullish | |
| $1.05 | $1.93 | $3.69 | +57% | Bullish | |
| $1.32 | $2.54 | $4.96 | +106% | Bullish | |
| $1.66 | $3.31 | $6.63 | +169% | Bullish | |
| $1.48 | $3.28 | $7.22 | +167% | Bullish | |
| $3.76 | $8.35 | $19.21 | +579% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.81 | $1.23 | $1.48 | +0.00% |
| June 2026 | $1.07 | $1.28 | $1.59 | +4.14% |
| July 2026 | $1.00 | $1.23 | $1.56 | -4.33% |
| August 2026 | $1.03 | $1.27 | $1.65 | +3.91% |
| September 2026 | $1.07 | $1.33 | $1.76 | +4.67% |
| October 2026 | $0.9933 | $1.25 | $1.68 | -5.91% |
| November 2026 | $0.9453 | $1.20 | $1.63 | -3.96% |
| December 2026 | $1.01 | $1.30 | $1.78 | +7.82% |
Click any year to see its month-by-month SLSN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Solesence, Inc.'s 2026 outlook centres on $1.23, within a $0.81 to $1.78 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SLSN could reach as high as $2.32, with a base case around $1.54 and support toward $1.11 — roughly +25% from $1.23. Momentum favours further upside here.
Expect SLSN to range from $1.33 to $3.13 through 2028. The $1.96 average target implies a +59% move from current prices. That is up +27% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The SLSN price prediction for 2029 points to an average of $2.28 (low $1.47, high $3.82) — a potential gain of +85% on today's $1.23. Momentum favours further upside here.
In 2030, SLSN is projected to trade between $1.25 and $3.54, averaging $2.03 — a potential gain of +65% from today's $1.23. That is -11% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Solesence, Inc.'s 2031 outlook centres on $2.09, within a $1.23 to $3.76 range. That is up +3% on the projected 2030 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2032, SLSN could reach as high as $4.00, with a base case around $2.15 and support toward $1.21 — roughly +75% from $1.23. Buyers look set to stay in control over this stretch.
Expect SLSN to range from $1.05 to $3.69 through 2033. The $1.93 average target implies a +57% move from current prices. That is -10% versus the projected 2032 average. Momentum favours further upside here.
The SLSN price prediction for 2034 points to an average of $2.54 (low $1.32, high $4.96) — a potential gain of +106% on today's $1.23. Buyers look set to stay in control over this stretch.
In 2035, SLSN is projected to trade between $1.66 and $6.63, averaging $3.31 — a potential gain of +169% from today's $1.23. That is up +31% on the projected 2034 average. Momentum favours further upside here.
Solesence, Inc.'s 2040 outlook centres on $3.28, within a $1.48 to $7.22 range. That is -1% versus the projected 2035 average. That marks a +167% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SLSN could reach as high as $19.21, with a base case around $8.35 and support toward $3.76 — roughly +579% from $1.23. Momentum favours further upside here.
Investing $1,000 in SLSN today (≈ 813.00813 SLSN) could be worth
$6,790.93
+$5,790.93 (+579%) by 2050 · US Dollar
Based on the average projected SLSN price of $8.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLSNwould be worth at today's price.
$1,000 invested in SLSN on May 27, 2025 (≈ 248.75622 SLSN) would be worth
$305.97
-$694.03 (-69.4%) today · 0.31× · US Dollar
Based on a SLSN entry price of $4.02 vs. today's $1.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.36 | $904.41 | -9.6% |
| 1 month ago | $1.39 | $884.89 | -11.5% |
| 3 months ago | $1.31 | $938.93 | -6.1% |
| 6 months ago | $2.29 | $537.12 | -46.3% |
| 1 year ago | $4.02 | $305.97 | -69.4% |
| All time (5.0y) ago | $1.55 | $793.55 | -20.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLSN forecast.
Our base-case forecast reaches $2.50 around 2034.
Implied market cap at $2.50: $176.58M
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising average prices and meaningful upside over time. In 2027, the avg is $1.58 with a min of $1.13 and a max of $2.37 (ROI 26.6%, sentiment BULLISH). By 2028, the avg is $2.00 and the max is $3.20 (ROI 60.8%).
The pattern continues through 2029 with an avg of $2.34 and a max of $3.92 (ROI 87.8%), and 2030 with an avg of $2.06 and a max of $3.59 (ROI 65.5%).
The long-range path remains bullish, with 2031 at $2.14 (ROI 71.9%), 2032 at $2.23 (ROI 78.8%), and 2033 at $1.95 (ROI 57). By 2034 the avg rises to $2.65 (ROI 112.5%), and 2035 to $3.46 (ROI 178.1%). The forecast extends into 2040 with an avg of $3.43 (ROI 175.6%), and the ultimate marquee figure appears in 2050 with an avg of $8.72 (ROI 600.2%), a max of $20.05, and bullish sentiment.
These numbers illustrate a substantial upside from the current level, though they are estimates and not guarantees. The forecast acknowledges uncertainty and the potential for volatility to influence outcomes across years, with the highest leverage appearing toward the later years as indicated by the 2050 targets.
Tap a question to reveal the answer.
For 2030 the forecast shows min $1.27, avg $2.06, max $3.59 with ROI 65.5% and sentiment BULLISH.
The forecast indicates bullish sentiment from 2027 onward and rising averages through 2050, with an avg of $8.72 and max of $20.05 in 2050, corresponding to an ROI of 600.2%. These are estimates, not guarantees.
The 2040 forecast shows max $7.55, so $10 is not projected by 2040; by 2050 the max is $20.05.
Current price is $1.25 and market cap is $87.94M. The stock ranks 4309 by market capitalization.
The 2027 forecast lists avg $1.58, min $1.13, max $2.37 with ROI 26.6% and sentiment BULLISH.
Solesence, Inc. Community Discussion
0Share your Solesence, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.